Get the Stockscreener App
141.96
2.80%
3.87
Pre-market:
143.02
1.06
+0.75%
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $141.96, with a volume of 854.58K.
It is up +2.80% in the last 24 hours and down -4.73% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$138.09
Open:
$138.27
24h Volume:
854.58K
Relative Volume:
1.19
Market Cap:
$7.63B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-15.40
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-1.39%
1M Performance:
-4.73%
6M Performance:
-12.89%
1Y Performance:
-17.33%
1-Day Range:
$135.29
$142.01
1-Week Range:
$135.29
$149.84
52-Week Range:
$133.70
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
141.96 | 7.42B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
JPMorgan Chase & Co. Cuts Stake in Masimo Corporation $MASI - MarketBeat
Will Masimo Corporation (3M4) stock remain on Wall Street radarMarket Trend Review & Free Real-Time Volume Trigger Notifications - Newser
Stifel reiterates Buy rating on Masimo stock with $180 price target - Investing.com Canada
What's Going On With Masimo Stock Thursday?Masimo (NASDAQ:MASI) - Benzinga
Needham reiterates Hold rating on Masimo stock after investor day By Investing.com - Investing.com
BTIG Raises Price Target for Masimo (MASI) to $200 | MASI Stock News - GuruFocus
Masimo stock price target raised to $200 from $198 at BTIG on growth outlook - Investing.com
Masimo Gives Company Update at 2025 Investor Day - Orange County Business Journal
Masimo (NASDAQ: MASI) targets ~30% margin, $8.00 EPS in 2028 plan for durable growth - Stock Titan
Is Masimo Corporation stock attractive for ETFsEarnings Miss & Free Reliable Trade Execution Plans - Newser
Will Masimo Corporation (3M4) stock test record highs in 2025Oil Prices & Reliable Trade Execution Plans - Newser
How Masimo Corporation (3M4) stock reacts to weak economyEarnings Recap Report & Weekly Top Gainers Alerts - Newser
What downside risks could hit Masimo Corporation (3M4) stockWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
Needham reiterates Hold rating on Masimo stock ahead of investor day By Investing.com - Investing.com South Africa
How Investors May Respond To Masimo (MASI) CEO Transition and Refocus on Core Monitoring Business - Yahoo Finance
Schroder Investment Management Group Boosts Stake in Masimo Corporation $MASI - MarketBeat
American Century Companies Inc. Raises Stock Holdings in Masimo Corporation $MASI - MarketBeat
MasimoPriced For Too Much Growth - Yahoo Finance
Legal & General Group Plc Increases Position in Masimo Corporation $MASI - MarketBeat
Masimo Corporation $MASI Stake Lessened by BLI Banque de Luxembourg Investments - MarketBeat
Grantham Mayo Van Otterloo & Co. LLC Takes Position in Masimo Corporation $MASI - MarketBeat
XTX Topco Ltd Takes Position in Masimo Corporation $MASI - MarketBeat
Rhumbline Advisers Raises Holdings in Masimo Corporation $MASI - MarketBeat
VP Ahmed Files To Sell 3,229 Of Masimo Corp [MASI] - TradingView
Zacks Research Brokers Reduce Earnings Estimates for Masimo - MarketBeat
Advisors Asset Management Inc. Sells 2,905 Shares of Masimo Corporation $MASI - MarketBeat
Zacks Research Has Pessimistic Outlook of Masimo Q2 Earnings - MarketBeat
Masimo Corporation (MASI) Stock Forecasts - Yahoo Finance
Piper Sandler maintains Overweight rating on Masimo stock ahead of Investor Day By Investing.com - Investing.com Nigeria
Masimo's (MASI) "Buy" Rating Reaffirmed at BTIG Research - MarketBeat
Here's Why Masimo (MASI) is a Strong Growth Stock - sharewise.com
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Masimo Wins $634M Patent Fight with Apple - Orange County Business Journal
First Week of January 2026 Options Trading For Masimo (MASI) - Nasdaq
BTIG Reiterates Buy Rating on MASI with $198 Price Target | MASI Stock News - GuruFocus
Entropy Technologies LP Grows Stake in Masimo Corporation $MASI - MarketBeat
Masimo Corporation Expands Beyond Pulse Oximetry - Smartkarma
iPhone Pocket, China Sales, $600 Million Patent Case And More: This Week In Appleverse - Benzinga
Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know - Finviz
Masimo initiated with a Neutral at BofA on lack of imminent growth inflection - MSN
Westfield Capital Management Co. LP Increases Stake in Masimo Corporation $MASI - MarketBeat
Masimo initiated with a Neutral at BofA - MSN
Masimo Corp. Explores New Frontiers in Sleep Therapy with PROSOMNIA Study - MSN
Masimo Corporation $MASI Shares Purchased by Geode Capital Management LLC - MarketBeat
SG Americas Securities LLC Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat
Will Masimo Corporation (3M4) stock outperform global peersTrade Exit Summary & Reliable Price Breakout Alerts - newser.com
Is Masimo Corporation (3M4) stock a buy before new product rolloutWeekly Investment Report & Entry Point Strategy Guides - newser.com
How Masimo Corporation (3M4) stock reacts to Fed tightening2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Verdict: Apple Hit With $634 Million in Damages in Masimo Lawsuit; Another Shoe May Drop - Strata-gee.com
Masimo Corporation stock volume spike explainedJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):